AI-generated analysis. Always verify with the original filing.
Evofem Biosciences, Inc. issued a press release on March 11, 2026, announcing its financial results. The filing includes Item 2.02 for results of operations and financial condition, Item 7.01 referencing Exhibit 99.2, and Item 9.01 listing Exhibits 99.1 and 99.2.
Event Type
Disclosure
Mandatory
Variant
8-K
. Results of Operations and Financial Condition. On March 11, 2026, Evofem Biosciences, Inc. (the “Company”) issued a press release announcing its financial res
of this Current Report on Form 8-K (including Exhibit 99.2) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as am
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated March 11, 2026 99.2 Corporate presentation prepared as of Mar